This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Martin M, Moore L, Quilici S, File T, GARAU J, Kubin M, Evers T.The impact of antimicrobial resitance on the cost-effectiveness of empirical treatment of community-acquired pneuonia in France, Belgium and Germany. European Respiratory Journal Supplement 30 (Suppl. 51): 677 (plus poster) abstr. E3938, Sep 2007
Rights and permissions
About this article
Cite this article
Moxifloxacin dominates for CAP. Pharmacoecon. Outcomes News 539, 6 (2007). https://doi.org/10.2165/00151234-200705390-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705390-00009